Seeking Alpha
What is your profession? ×
Long/short equity, momentum, special situations
Profile| Send Message|
( followers)

By: Brendan Gilmartin (NASDAQ:PCLN) is scheduled to report 3Q 2012 earnings after the close of trading on Tuesday, February 26, with a conference call to follow at 4:30 p.m. EST. Priceline shares have been climbing higher in recent months, benefiting from stabilization in Europe, expansion in Asia and growth in the North American market. With the shares recently hurdling back above the 700-level, the market is pricing in a solid quarter. Anything less could be seen as a major disappointment.

Outliers And Strategy

Key measures for Priceline:

  • Non-GAAP Earnings Per Share: Priceline previously indicated it sees Non-GAAP net income in the range of $6.12 to $6.57 per share. The current consensus is above the high end of that range at $6.54 (high estimate on the Street is $6.87).
  • Revenues: In its prior release, Priceline indicated it expects 4Q 2012 revenue increasing 15% to 22% year over year ($1.0 bln). That would equate to about $1.15 bln to $1.22 bln. The estimate is $1.19 bln.
  • Adjusted EPS Guidance (3Q 2012): The forward outlook is critical for Priceline. The consensus is $5.14. (Yahoo Finance)

Given the recent run-up in Priceline shares, look for Non-GAAP EPS and revenues to come in toward the high end of forecasts. Also note that guidance typically drives the price action in the shares after the results are released.

Sympathy Plays: Expedia (NASDAQ:EXPE), Travelzoo (NASDAQ:TZOO), TripAdvisor Inc. (NASDAQ:TRIP) and Orbitz Worldwide (NYSE:OWW).

Recent News

  • 01/31: Morgan Stanley downgraded from Overweight to Equal-weight, and reduced the price target from $750 to $730, according to a report on The firm cited growth concerns for the downgrade, along with increased customer acquisition costs, increased competition, and limited upside to the reduced $730 price target. The firm also cut earnings guidance for FY2013 and FY2014.
  • 01/03: Bank of America/Merrill Lynch upgraded to a Buy rating and increased its target from $690 to $770, according to a post on The firm cited several catalysts, including a modest recovery in Europe, the recently announced Kayak acquisition, and upside for its 2013 estimates.
  • 12/10: Deutsche Bank downgraded from Buy to a Hold rating and reduced the price objective from $800 to $710, according to a post on The firm cited increased competitive dynamics heading into 2013, particularly in Europe.

Technical Review shares recently rallied back toward the $700 level, before stalling out. Should earnings or forward guidance disappoint, look for initial support near $680, with downside risk to $670 (just above the 50-Day SMA), $650, and the 200-Day SMA near $640. Conversely, there is initial resistance at the aforementioned $700-level, followed by the January peak near $720. (Chart courtesy of

Summary shares are up more than 10% YTD and fetching just 18.3x forward earnings in advance of the 4Q 2012 earnings release after the close on Tuesday. Bulls are quick to argue that Priceline dominates the online travel market, particularly on the international scene with a dominant foothold in Europe via, along with assets in Asia. The recent lift in the share price is also attributable to the underlying pickup in the global economy and recently announced acquisition of Despite this favorable backdrop, however, Priceline is facing increased competition, both domestic and abroad, along with rising marketing and customer acquisition costs. With that said, the bar is set pretty high ahead of the 4Q earnings release, leaving Priceline vulnerable to even the slightest missteps.

DISCLAIMER: By using this report, you acknowledge that Selerity, Inc. is in no way liable for losses or gains arising out of commentary, analysis, and or data in this report. Your investment decisions and recommendations are made entirely at your discretion. Selerity does not own securities in companies that they write about, is not an investment adviser, and the content contained herein is not an endorsement to buy or sell any securities. No content published as part of this report constitutes a recommendation that any particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.